RightEye: New Research Demonstrates Reliability of Eye Tracking Data to Identify and Measure Severity of Traumatic Brain Injuries

Source: RightEye

RightEye announced the results of a recent study published in the peer-reviewed journal Concussion that shows how RightEye’s FDA-cleared technology accurately measures deficits in certain eye movements that result from a concussion. The data provided by RightEye eye tracking technology offers an objective, reliable and quantifiable way of differentiating between individuals with different severities of concussion, as well as providing guidance on the path to recovery, according to a company news release.

Given the limitations and inconsistencies of today’s most common TBI screening protocols, there is a need for more objective and specific methods to assist doctors in the detection and diagnosis of TBIs. Unlike conventional “follow-my-finger” screening methods that rely solely on a practitioner’s observations, RightEye’s eye-tracking technology quickly delivers precise, objective and quantifiable eye movement data by surveying the eye several times per second and recording its movement. The technology uncovers even the smallest eye movement deficits that are often missed using traditional/analog screening methods, such as vestibular/ocular-motor screening (VOMS), according to RightEye.

The study found that functional vision tests using RightEye’s eye-tracking technology are a useful, precise and objective measure of underlying neurological health that indicates the presence of TBIs. Furthermore, particular metrics have shown promise in being able to differentiate mild, moderate and severe TBI cases.

“Concussions are a significant international public health concern, yet the methods currently used for its detection are manual and subjective. In addition, not all concussions are the same, yet patients usually lack a clear understanding of the severity of a concussion as well as the road to recovery. Eye tracking provides doctors and other healthcare professionals with a fast and objective tool for assessing concussions and other TBIs,” Dr. Melissa Hunfalvay, co-founder and chief science officer, RightEye, LLC, and a co-author of the study, said in the news release. “This study demonstrates that digital eye tracking tests, such as RightEye’s Brain Health EyeQ, are capable of providing doctors with the data they need to quickly and precisely uncover abnormal eye movement behavior that can be associated with concussions of varying severity.”

Eye tracking can be used by a wide range of medical professionals, ranging from optometrists and other vision care providers, to neurologists and primary care physicians. Beyond helping doctors detect and diagnose concussions, eye tracking technology can be used to assist in determining appropriate treatment programs, and aide in determining when it is safe for patients to return to normal activity after sustaining a concussion.


Related Content